Alaunos Therapeutics Inc [NASDAQ: TCRT] stock went on an upward path that rose over 46.94% on Tuesday, amounting to a one-week price increase of more than 34.10%.
Over the last 12 months, TCRT stock dropped by -88.07%. The one-year Alaunos Therapeutics Inc stock forecast points to a potential upside of 99.81. The average equity rating for TCRT stock is currently 3.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $3.45 million, with 1.60 million shares outstanding and 1.38 million shares in the current float. Compared to the average trading volume of 13.52K shares, TCRT stock reached a trading volume of 5343720 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Alaunos Therapeutics Inc [TCRT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TCRT shares is $1125.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TCRT stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Alaunos Therapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 04, 2022.
The Average True Range (ATR) for Alaunos Therapeutics Inc is set at 0.19, with the Price to Sales ratio for TCRT stock in the period of the last 12 months amounting to 345.31. The Price to Book ratio for the last quarter was 1.27, with the Price to Cash per share for the same quarter was set at 1.05.
TCRT Stock Performance Analysis:
Alaunos Therapeutics Inc [TCRT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 34.10. With this latest performance, TCRT shares gained by 37.58% in over the last four-week period, additionally sinking by -30.55% over the last 6 months – not to mention a drop of -88.07% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TCRT stock in for the last two-week period is set at 74.26, with the RSI for the last a single of trading hit 81.45, and the three-weeks RSI is set at 67.54 for Alaunos Therapeutics Inc [TCRT]. The present Moving Average for the last 50 days of trading for this stock 1.6000, while it was recorded at 1.6300 for the last single week of trading, and 2.7800 for the last 200 days.
Insight into Alaunos Therapeutics Inc Fundamentals:
Alaunos Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.30 and a Current Ratio set at 4.30.
Alaunos Therapeutics Inc [TCRT] Institutonal Ownership Details
There are presently around $4.51%, or 5.25%% of TCRT stock, in the hands of institutional investors. The top three institutional holders of TCRT stocks are: MSD PARTNERS, L.P. with ownership of 1.01 million shares, which is approximately 6.3082%. MAGNOLIA CAPITAL ADVISORS LLC, holding 20607.0 shares of the stock with an approximate value of $$14404.0 in TCRT stocks shares; and MAGNOLIA CAPITAL ADVISORS LLC, currently with $$11300.0 in TCRT stock with ownership which is approximately 0.101%.
